Condition

Hepatitis

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 25 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials25

Recruiting1

Common interventions25

Lead sponsors shown15

Clinical trials

25 shown

Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income CountriesNCT06395129 · 2024-09-13

The Living With a Long-Term Condition StudyNCT06072287 · 2023-06-28

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesNCT05635266 · 2021-10-26

Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2NCT04846010 · 2021-03-01

Liver Toxicity in Lung Cancer Patients Treated With Immune-checkpoint Inhibitors.NCT04595734 · 2020-01-07

Monitoring the IMmUological TOXicity of DrugsNCT03480529 · 2018-03-01

Addiction, HIV and Tuberculosis in Malaysian Criminal Justice SettingsNCT03089983 · 2017-08-21

Genomic Resources for Enhancing Available Therapies (GREAT1.0) StudyNCT04306939 · 2014-11-01

Comorbidities and Virologic Outcome Among Patients on Anti-retroviral Therapy in Rural LesothoNCT02126696 · 2014-05-01

An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected PatientsNCT02103439 · 2013-06-06

Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent PatientsNCT01645033 · 2012-04-01

Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIVNCT01443923 · 2011-09-01

The Health Access and Recovery Peer ProgramNCT01725815 · 2011-06-01

Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV PreventionNCT01142882 · 2010-02-01

ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIVNCT00901524 · 2009-06-01

Effectiveness of Hepatitis A Virus Vaccination Among Homosexual Males at Risk for Hepatitis A InfectionNCT01102296 · 2009-06-01

Telesonography Adaptation and Use to Improve the Standard of Patient Care Within a Dominican CommunityNCT00591968 · 2008-01-01

HIV-HCV Coinfection: Impact of Immune DysfunctionNCT00575315 · 2004-07-01

S-Adenosylmethionine Therapy for Non-Alcoholic SteatohepatitisNCT00108589 · 2004-01-01

Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)NCT00160407 · 2003-10-01

A Network & Dyad HIV Prevention Intervention for IDU's - 1NCT00218335 · 2003-06-01

Treating Nonalcoholic Steatohepatitis (NASH) With MetforminNCT00063232 · 2003-06-01

Treating Nonalcoholic Steatohepatitis With PioglitazoneNCT00062764 · 2003-06-01

Manhattan HIV/Hepatology Brain BankNCT00300209 · 1998-09-01

A Controlled Prospective Study of Transfusion-Associated HepatitisNCT00004848 · 1981-07-01

Common interventions

Leading sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2 Yale University 2 All Natural Medicine Clinic, LLC 1 ANRS, Emerging Infectious Diseases 1 Biocad 1 Edward Via Virginia College of Osteopathic Medicine 1 Emory University 1 Groupe Hospitalier Pitie-Salpetriere 1 Icahn School of Medicine at Mount Sinai 1 Johns Hopkins Bloomberg School of Public Health 1 King's College London 1 Médecins du Monde 1 National Development and Research Institutes, Inc. 1 National Institute of Allergy and Infectious Diseases (NIAID) 1 National Institutes of Health Clinical Center (CC) 1

Trial status mix

COMPLETED17

UNKNOWN5

RECRUITING1

SUSPENDED1

TERMINATED1

Phase mix

NA6

PHASE25

PHASE32

PHASE42

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.